Elagolix, an Oral GnRH Antagonist, Versus Subcutaneous Depot Medroxyprogesterone Acetate for the Treatment of Endometriosis: Effects on Bone Mineral Density
Crossref DOI link: https://doi.org/10.1177/1933719114549848
Published Online: 2014-12-30
Published Print: 2014-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Carr, Bruce
Dmowski, W. Paul
O’Brien, Chris
Jiang, Ping
Burke, Joshua
Jimenez, Roland
Garner, Elizabeth
Chwalisz, Kristof
Text and Data Mining valid from 2014-11-01
Version of Record valid from 2014-11-01
Article History
First Online: 30 December 2014